Virus Outbreak Fuels Volatility in Some Biotech Stocks 
 The deadly coronavirus outbreak is sparking big moves among biotechnology stocks, a volatile sector where companies can flourish or struggle depending on their progress in developing new medical treatments.
 Shares of Moderna Inc., a Cambridge, Mass.-based biotech company, rose 5.2% to $22.02 in afternoon trading Wednesday after it said in a regulatory filing that it was working with the National Institutes of Health and two of its affiliates “on a potential vaccine response to the current public health emergency.” NIH is the...